Boğaziçi Ventures

Bogazici Ventures is one of Turkey’s most established venture firms, operating across seed, Series A, and Series B with cheque sizes from $500k to $5M and a multi-stage capability that extends into pre-IPO situations through specialised vehicles. The firm has explicit exposure to digital health, health IT software, and AI, and sits inside an Istanbul ecosystem that has produced credible regional SaaS exits. Founders best matched to Bogazici are Turkish or Turkish-diaspora teams building B2B health software, clinical workflow platforms, or AI-enabled diagnostic tools with clear ambitions to expand into MENA and CEE. Founders running pure consumer wellness, US-only plays, or research-stage biotech are a poor fit. The cleanest intro path is via a portfolio CEO, the Bogazici University alumni network, or one of the larger Istanbul corporate venture arms (Turkcell, Garanti) that frequently syndicate alongside the fund. In a first meeting, lead with revenue traction in TRY-denominated terms with FX-hedged forecasting, hospital or payer logos, and a credible international expansion narrative that does not depend on Turkey alone, given lira volatility. Founders should also be prepared to discuss data residency and KVKK compliance, because Turkish health data regulations are strict and any AI-enabled product will get probed on this front. Caveats: Turkey’s macro instability is a structural drag on follow-on capital, so founders should plan for international Series A or B partners early, and Bogazici can help here through its regional syndicate relationships. The firm’s cheque sizes are mid-market by global standards, so expect to syndicate with co-leads on larger rounds. Confirm fund vintage and reserves directly, and request a recent portfolio sheet to verify pacing in healthcare specifically rather than the firm’s broader tech book.